Press Releases for BRL

Press Releases
Warner Chilcott and Barr Announce Settlement of Femcon(R) Fe Patent Challenge
U.S. Federal Trade Commission Clears Teva’s Acquisition of Barr
U.S. Federal Trade Commission Clears Teva's Acquisition of Barr
Teva and Barr Receive European Commission Approval For Acquisition
Teva and Barr Receive European Commission Approval for Acquisition
Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
Teva Draws on $1.75 Billion Bridge Financing in Connection with Pending Barr Acquisition
FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
Barr Confirms Patent Challenge of Amrix(R) Extended-Release Capsules, 15mg & 30mg
Barr Shareholders Approve Pending Teva Acquisition
Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
Barr Reports Third Quarter 2008 GAAP Earnings of $0.28 Per Share; Adjusted Earnings of $0.83 Per Share
Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
Teva and Barr Provide Update on Acquisition - Business Wire
Teva and Barr Provide Update on Acquisition - PR Newswire
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Barr Confirms Patent Challenge of Oxytrol(R)
Barr Confirms Patent Challenge of Opana(R) ER Extended-Release Tablets, 5 mg, 10 mg, 20 mg and 40 mg
Barr Revises Timing of Its Earnings Conference Call to Discuss the Results for the Third Quarter of Calendar 2008 to 9:00 AM Eastern Time
Barr Says Court of Appeals Upholds 2005 District Court Decision on 1997 Cipro(R) Settlement
Barr Announces Date for Special Shareholder Meeting
Zacks Analyst Blog Highlights: Actions Semiconductor Corp., Barr Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Overstock.Com, Inc. And Sonic Innovations, Inc.
Zacks Bull and Bear of the Day Highlights: Telus Corp., Overstock.Com, Barr Pharmaceuticals, Actions Semiconductor and Sonic Innovations
Barr Will Host An Earnings Conference Call on November 6, 2008 to Discuss the Results for the Third Quarter of Calendar 2008
Ready and Willing, but Unable? Survey Reveals Boomers Desire Sex, But Face Physical Challenges
Barr Receives Approval for Generic Version of Razadyne(R) ER Capsules
Teva and Barr Receive FTC Request for Additional Information - Business Wire
Teva and Barr Receive FTC Request for Additional Information - PR Newswire
Barr Receives Approval for Generic Version of Razadyne(R) Tablets
Barr Announces Favorable Ruling in Razadyne(R) Patent Challenge
Barr Confirms Patent Challenge of FazaClo(R) Orally Disintegrating Tablets, 25mg and 100mg
/C O R R E C T I O N -- Barr Pharmaceuticals, Inc. (NYSE: BRL)/
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
First At-Home Screening Test for Amniotic Fluid Leakage During Pregnancy Now Available
Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges
Wall Street News Alert: Breaking News Alert - GRCO! August 7, 2008
Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
Barr Confirms Patent Challenge of Fentora(R) Tablets
Teva and Barr Invites Public to Listen to Webcast
Revised Analyst Reports for International Business Machines Corporation, Barr Pharmaceuticals Inc., The Home Depot Inc., And Schlumberger Limited
Teva to Acquire Barr - Business Wire
Teva to Acquire Barr - PR Newswire
Barr Will Host an Earnings Conference Call on August 7, 2008 to Discuss the Results for the Second Quarter of Calendar 2008
Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg
Barr Confirms Patent Challenge of Entocort(R), 3mg Enteric Coated Capsules
Barr Announces Approval of Generic Yasmin(R) - Jun 1 2008 3:25PM
BellwetherReport.com Analyst Report on SIRF, CFX, BRL, and DRS - May 27 2008 1:17AM
Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share - Jun 1 2008 3:24PM
Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008